Curriculum Vitae Michalis (Michael) V. Karamouzis - MyLoyalCard

metastatic head and neck squamous cell carcinoma (HNSCC): updated results of a
phase II trial”, 44 th ASCO Annual Meeting, Chicago, Illinois, U.S.A., May 30-
June 3, 2008.
11) E. G. Iliopoulou, P. Kountourakis, M. V. Karamouzis, et al.: “A phase I trial of
adoptive transfer of allogeneic natural killer (NK) cells in patients (pts) with
advanced non-small cell lung cancer (NSCLC)”, ASCO Annual Meeting, Orlando,
Florida, U.S.A., May 29-June 2, 2009.
12) A. Argiris, M.V. Karamouzis, W.E. Gooding, B. Branstetter, S. Zhong, L.E. Raez,
P. Savvides, M. Romkes: “Pemetrexed (P) and bevacizumab (B) in patients (pts)
with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck
(SCCHN): Final results and correlation with TS, MTHFR, and VEGF gene
polymorphisms”, ASCO Annual Meeting, Chicago, Illinois, U.S.A., June, 2010.
13) M.V. Karamouzis, N. Dioufa, E. Farmaki, C. Piperi, H. Kiaris, A. Papavassiliou:
“Essential role of p53 of stromal fibroblasts (fibs) in the reciprocal interaction
between PC3 prostate cancer cells and stromal fibs”, ASCO Annual Meeting,
Chicago, Illinois, U.S.A., June, 2011.
Participation in scientific societies
1) Full ESMO Member (European Society of Medical Oncology) – Chair of ESMO-
Young Oncologists Committee (2010-2012)
2) Active ASCO Member (American Society of Clinical Oncology).
3) Associate AACR Member (American Association of Cancer Research).
Last Update: October 2012
12
12